Aculys Pharma is a pharmaceutical company that develops drugs and innovative medical treatments for neurological and psychiatric disorders.
Aculys Pharma has raised $22.9M in total funding. The most recent round was Series B. The last funding was announced in March 2022.
Aculys Pharma's investors include Mitsubishi UFJ Capital, SoftBank Vision Fund, Spiral Capital, ANRI, Global Founders Capital.
Aculys Pharma is headquartered in Tokyo, Japan.
Aculys Pharma is a pharmaceutical company that develops drugs and innovative medical treatments for neurological and psychiatric disorders.
Aculys Pharma is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aculys Pharma — Funding & Investors." VCBacked, March 27, 2022, https://www.vcbacked.co/company/aculys-pharma. Accessed September 14, 2026.
VCBacked. (2022). Aculys Pharma — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/aculys-pharma
{{cite web |title=Aculys Pharma — Funding & Investors |url=https://www.vcbacked.co/company/aculys-pharma |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated